The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
From traditional Chinese medicine to rational cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Farnsworth, N., Akerele, O., & Bingel, A. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90016-x · Cited by 1,362
Mechanisms of action of arsenic trioxide.
Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 1,088
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier, J. L., Martinez, M.-C. M., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., Depierreux, M. F., De Pauw, L., Abramowicz, D., Vereerstraeten, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422301 · Cited by 983
The Pharmacology of Chinese Herbs
Huang, K. (1998) · Routledge eBooks · doi:10.4324/9780367801892 · Cited by 876
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3852 · Cited by 826
UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )
Ortier, L. N., Arie, M., Chmeiser, H. S., Rlt, V. O. M. A., Ieler, H. A. B., Etein, M. I. P., Epierreux, M. I. F. D., Auw, L., Bramowicz, D. A. A., & Ereerstraeten, P. I. V. (2014) · Cited by 814
Wink, M. (1988) · Theoretical and Applied Genetics · doi:10.1007/bf00303957 · Cited by 666
The anti-malarial artesunate is also active against cancer
Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., & Chitambar, C. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.767 · Cited by 564
Self-citationPharmacology and applications of chinese materia medica
(1987) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(87)90305-9 · Cited by 555
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Arlt, V. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.4.265 · Cited by 505
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H. O., Hengstler, J. G., Halatsch, M.-E., Volm, M., Tew, K. D., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.382 · Cited by 428
Self-citationShenai, B. R., Sijwali, P. S., Singh, A., & Rosenthal, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004459200 · Cited by 344
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Self-citationInhibition of translation in eukaryotic systems by harringtonine
FRESNO, M., JIMÉNEZ, A., & VÁZQUEZ, D. (1977) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1977.tb11256.x · Cited by 295
Efferth, T. (2007) · Planta Medica · doi:10.1055/s-2007-967138 · Cited by 269
Self-citationMolecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Efferth, T. (2006) · Current Drug Targets · doi:10.2174/138945006776359412 · Cited by 262
Self-citationReview of randomised controlled trials of traditional Chinese medicine
Tang, J.-L., Zhan, S.-Y., & Ernst, E. (1999) · BMJ · doi:10.1136/bmj.319.7203.160 · Cited by 249
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Arsenic Trioxide: New Clinical Experience With an Old Medication in Hematologic Malignancies
Douer, D., & Tallman, M. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.217 · Cited by 236
Capsaicin Inhibits in Vitro and in Vivo Angiogenesis
Min, J.-K., Han, K.-Y., Kim, E.-C., Kim, Y.-M., Lee, S.-W., Kim, O.-H., Kim, K.-W., Gho, Y. S., & Kwon, Y.-G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3250 · Cited by 214
Homoharringtonine: History, current research, and future directions
Kantarjian, H. M., Talpaz, M., Santini, V., Murgo, A., Cheson, B., & O'Brien, S. M. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1591::aid-cncr1485>3.0.co;2-u · Cited by 190
Artesunate in the treatment of metastatic uveal melanoma - first experiences
Berger, T., Dieckmann, D., Efferth, T., Schultz, E., Funk, J.-O., Baur, A., & Schuler, G. (2005) · Oncology Reports · doi:10.3892/or.14.6.1599 · Cited by 176
Self-citationMechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
EFFERTH, T. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.04.003 · Cited by 169
Self-citationNovel Aspects of Natural and Modified Vinca Alkaloids
Duflos, A., Kruczynski, A., & Barret, J.-M. (2012) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011023354452 · Cited by 166
Toward the rational design of protein kinase casein kinase-2 inhibitors
Sarno, S., Moro, S., Meggio, F., Zagotto, G., Ben, D. D., Ghisellini, P., Battistutta, R., Zanotti, G., & Pinna, L. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00185-7 · Cited by 156
Vascular endothelial growth factor (VEGF) inhibition—a critical review
Sousa Moreira, I., Alexandrino Fernandes, P., & Joao Ramos, M. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007780058687 · Cited by 110
Abelson, P. H. (1990) · Science · doi:10.1126/science.2300807 · Cited by 106
Zhang, C., Mei, X., Liu, L., & Yu, L. J. (2000) · Biotechnology Letters · doi:10.1023/a:1005684901329 · Cited by 104
Guo, Q., Lin, S., You, Q., Gu, H.-Y., Yu, J., Zhao, L., Qi, Q., Liang, F., Tan, Z., & Wang, X. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.046 · Cited by 104
The Anti-Angiogenic Effect of Sinomenine
Kok, T.-W., Yue, P. Y. K., Mak, N. K., Fan, T., Liu, L., & Wong, R. N. (2005) · Angiogenesis · doi:10.1007/s10456-005-2892-z · Cited by 103
Molecular modes of action of cantharidin in tumor cells
Efferth, T., Rauh, R., Kahl, S., Tomicic, M. T., Böchzelt, H., Tome, M. E., Briehl, M. M., Bauer, R., & Kaina, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.12.003 · Cited by 99
Self-citationKantarjian, H. M., Talpaz, M., Smith, T. L., Cortes, J. E., Giles, F. J., Rios, M. B., Mallard, S., Gajewski, J., Murgo, A. J., Cheson, B. D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3513 · Cited by 92
The spindle assembly checkpoint: Preventing chromosome mis‐segregation during mitosis and meiosis
Malmanche, N., Maia, A. F., & Sunkel, C. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.081 · Cited by 87
Marín, D., Kaeda, J., Andreasson, C., Saunders, S., Bua, M., Olavarría, E., Goldman, J. M., & Apperley, J. F. (2005) · Cancer · doi:10.1002/cncr.20975 · Cited by 76
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 71
O'Brien, S. M., Giles, F. J., Talpaz, M., Cortes, J. E., Rios, M. B., Shan, J., Thomas, D. A., Andreeff, M., Kornblau, S. M., Faderl, S. H., et al. (2003) · Cancer · doi:10.1002/cncr.11620 · Cited by 66
Research priorities in traditional Chinese medicine
Tang, J.-L. (2006) · BMJ · doi:10.1136/bmj.333.7564.391 · Cited by 60
Bhisutthibhan, J., & Meshnick, S. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2397-2399.2001 · Cited by 55
Zhang, F., Jia, Z., Deng, Z., Wei, Y., Zheng, R., & Yu, L. (2002) · Planta Medica · doi:10.1055/s-2002-20255 · Cited by 52
Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?
Grem, J. L., Cheson, B. D., King, S. A., Leyland-Jones, B., & Suffness, M. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.14.1095 · Cited by 39
Telomerase and telomere dynamics in ageing and cancer: current status and future directions
Camarena, F. S., Serral, G. C., & Sampedro, F. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0028-1 · Cited by 36
Witte, R. S., Hsieh, P., Elson, P. J., Oken, M. M., & Trump, D. L. (1996) · Investigational New Drugs · doi:10.1007/bf00180819 · Cited by 19
Witte, R. S., Lipsitz, S. R., Goodman, T. L., Asbury, R. F., Wilding, G., Strnad, C. M., Smith, T. J., & Haller, D. G. (1999) · Investigational New Drugs · doi:10.1023/a:1006327418043 · Cited by 18
Microarray-based Prediction of Cytotoxicity of Tumor Cells to Arsenic Trioxide.
Efferth, T., & Kaina, B. (2004) · PubMed · Cited by 16
Self-citationCLINICAL STUDIES OF CAMPTOTHECIN AND DERIVATIVES
Soepenberg, O., Sparreboom, A., & Verweij, J. (2003) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/s0099-9598(03)60001-5 · Cited by 15
Cited by
Phenolic acids: Natural versatile molecules with promising therapeutic applications
Kumar, N., & Goel, N. (2019) · Biotechnology Reports · doi:10.1016/j.btre.2019.e00370 · Cited by 1,694
Huang, W.-Y., Cai, Y.-Z., & Zhang, Y. (2009) · Nutrition and Cancer · doi:10.1080/01635580903191585 · Cited by 1,009
Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
Dad, H. A., Gu, T.-W., Zhu, A.-Q., Huang, L.-Q., & Peng, L.-H. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.030 · Cited by 745
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical and Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 701
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Efferth, T. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.009 · Cited by 632
Self-citation
Metadata
- Authors
- Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 13
- Issue
- 8
- Pages
- 353-361
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2088694924
- Cited by
- 528
- References
- 50
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.